During chronic colitis, also the deregulation of Tgf-β signaling was partially restored compared to acutely DSS-treated mice as indicated by lack of Tgf-β upregulation and milder upregulation of Smad-3 in chronically DSS-treated compared to untreated mice. Here, SMAD3 is linked to colitis.